Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -1.77 is 85% above its 5-year average of -11.51, near the high end of its 5-year range (-15.57–-1.77).
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.41.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 17 comparable quarters.
EARNINGS PER SHARE (EPS)
-1.77
EARNINGS PER SHARE (EPS) AVG TTM
N/A
EARNINGS PER SHARE (EPS) AVG 3Y
-12.47
EARNINGS PER SHARE (EPS) AVG 5Y
-11.51
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
+85.81%
CURRENT VS 5Y AVG
+84.62%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Senti Biosciences, Inc.
Market Cap
$10.59M
Earnings Per Share (EPS)
-1.77
TTM Avg
N/A
3Y Avg
-12.47
5Y Avg
-11.51
Market Cap
$10.59M
Earnings Per Share (EPS)
-2.45
TTM Avg
-3.00
3Y Avg
-4.04
5Y Avg
-6.77
Market Cap
$10.65M
Earnings Per Share (EPS)
-16.82
TTM Avg
-28.56
3Y Avg
-28.65
5Y Avg
-34.30
Market Cap
$10.41M
Earnings Per Share (EPS)
-2.79
TTM Avg
-24.53
3Y Avg
-24.53
5Y Avg
-26.36
Market Cap
$10.51M
Earnings Per Share (EPS)
N/A
TTM Avg
-0.21
3Y Avg
-0.25
5Y Avg
-0.25
Market Cap
$10.41M
Earnings Per Share (EPS)
N/A
TTM Avg
-68.10
3Y Avg
-34.05
5Y Avg
-22.70
Market Cap
$10.38M
Earnings Per Share (EPS)
-1.92
TTM Avg
-10.95
3Y Avg
-6.49
5Y Avg
-5.26
Market Cap
$11.00M
Earnings Per Share (EPS)
-0.73
TTM Avg
-0.46
3Y Avg
-0.46
5Y Avg
-0.46
Market Cap
$11.01M
Earnings Per Share (EPS)
-3.20
TTM Avg
-7.58
3Y Avg
-60.73
5Y Avg
-69.78
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Senti Biosciences, Inc. (SNTI) | $10.59M | -1.77 | N/A | -12.47 | -11.51 |
| Pluri Inc. (PLUR)vs › | $10.59M | -2.45 | -3.00 | -4.04 | -6.77 |
| Lifeward Ltd. (LFWD)vs › | $10.65M | -16.82 | -28.56 | -28.65 | -34.30 |
| Tvardi Therapeutics, Inc. (TVRD)vs › | $10.41M | -2.79 | -24.53 | -24.53 | -26.36 |
| CytoMed Therapeutics Limited (GDTC)vs › | $10.51M | N/A | -0.21 | -0.25 | -0.25 |
| Polyrizon Ltd. (PLRZ)vs › | $10.41M | N/A | -68.10 | -34.05 | -22.70 |
| Satellos Bioscience Inc. (MSLE)vs › | $10.38M | -1.92 | -10.95 | -6.49 | -5.26 |
| Caring Brands, Inc. (CABR)vs › | $11.00M | -0.73 | -0.46 | -0.46 | -0.46 |
| BioVie Inc. (BIVI)vs › | $11.01M | -3.20 | -7.58 | -60.73 | -69.78 |
| MetaVia Inc. (MTVA)vs › | $10.15M | -4.07 | -23.25 | -137.85 | -1187.50 |
Trailing EPS (TTM)
$-1.77
Forward EPS (Est.)
$-0.78
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2024-12-31 | -11.49 |
| 2022-12-31 | -13.25 |
| 2021-12-31 | -12.67 |
| 2020-12-31 | -4.55 |
| 2019-12-31 | -15.57 |
